Description : Teneligliptin is a Novel Dipeptidyl Peptidase IV inhibitors for the treatment of type 2 diabetes with minimal risk of hypoglycemia and weight gain. TENeLIgliptin act on inCRETins with elevation of activated glucagon-like peptide 1 (GLP-1) levels and the resulting suppression of postprandial hyperglycemia.
Description : Teneligliptin is a Novel Dipeptidyl Peptidase IV inhibitors for the treatment of type 2 diabetes with minimal risk of hypoglycemia and weight gain. TENeLIgliptin act on inCRETins with elevation of activated glucagon-like peptide 1 (GLP-1) levels and the resulting suppression of postprandial hyperglycemia.
Description : Colistimethate sodium is a surface active agent which penetrates into and disrupts the bacterial cell membrane. It has been shown to have bactericidal activity against most strains of the following microorganisms.
Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae andPseudomonas aeruginosa
Indications: Acute or chronic infections caused by gram negative orgnisms
Storage: Store between 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59° to 86°F).
Store reconstituted solution in refrigerator 2° to 8°C (36° to 46°F) or between 20° to 25°C(68° to 77°F) and u
Description : Colistimethate sodium is a surface active agent which penetrates into and disrupts the bacterial cell membrane. It has been shown to have bactericidal activity against most strains of the following microorganisms.
Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae andPseudomonas aeruginosa
Indications: Acute or chronic infections caused by gram negative orgnisms
Storage: Store between 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59° to 86°F).
Store reconstituted solution in refrigerator 2° to 8°C (36° to 46°F) or between 20° to 25°C(68° to 77°F) and u